Is Tourette Syndrome Genetic? Heritability and Family Risk
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Tic Disorders, Tourette Syndrome & Repetitive Behaviors · Written by Artificial Sapiens
Yes. Tourette syndrome is substantially influenced by genetics. Family studies show that close biological relatives of people with Tourette syndrome or another chronic tic disorder have an elevated likelihood of tic disorders. Twin and population-register studies support heritable susceptibility, while DNA research reveals a complex combination of many common genetic variants and some rarer changes. Inheritance increases probability; it does not make Tourette syndrome inevitable. Fernandez, 2025 · CDC
An especially important number for families is the estimated 29.9% recurrence risk for any chronic tic disorder in first-degree relatives calculated in a 2020 study. This describes a broader group of tic disorders, not a 29.9% prediction of Tourette syndrome specifically for every child whose parent has Tourette syndrome. Heritability, the odds ratio found in a family study, and an individual child's chance are three distinct statistics. Heiman et al., 2020
What does it mean for Tourette syndrome to be genetic?
Tourette syndrome is a neurodevelopmental tic disorder. Its diagnostic pattern includes multiple motor tics and at least one vocal tic at some point during the illness, an onset before age 18, and more than one year since the first tic. Motor and vocal tics need not occur at the same moment. Diagnosis also requires excluding a substance effect and another medical cause. A single transient movement, noise, or habit cannot establish Tourette syndrome. CDC diagnostic criteria
Genetic susceptibility means that differences in DNA contribute to variations in the likelihood of developing a condition. In Tourette syndrome, numerous variants appear to contribute small effects across the population, and some rare inherited or newly arising variants may have more consequential effects in a subset of cases. Family, twin, sequencing, and genome-wide association research support this picture. No single DNA change accounts for typical Tourette syndrome in everyone who has it. Fernandez, 2025 · Willsey et al., 2017
Because the condition has complex inheritance, a child may develop Tourette syndrome when neither parent has the diagnosis, and a parent with Tourette syndrome may have children who never develop a chronic tic disorder. The same family may include Tourette syndrome, persistent motor or vocal tics, mild childhood tics that later diminish, and relatives without recognizable symptoms. These patterns are compatible with variable expression and differences in accumulated genetic risk.
Is Tourette syndrome inherited from the mother or the father?
Contributing genetic variants can be inherited from either parent. Typical Tourette syndrome does not follow a universal mother-only, father-only, X-linked, or single dominant-gene pattern. Some children inherit susceptibility variants from both sides of the family, while certain rare variants can arise de novo in the affected person. A parent can transmit contributing variants without having Tourette syndrome personally. Fernandez, 2025
The statement that a child shares about half of each biological parent's segregating DNA does not mean there is a 50% chance of Tourette syndrome. Fifty-percent recurrence figures apply to particular Mendelian inheritance situations, subject to penetrance. Tourette syndrome generally involves many genetic influences and a more complicated relationship between genotype and clinical outcome. The relevant family-risk evidence comes from studies that actually count diagnosed relatives, not from the fraction of DNA inherited. Heiman et al., 2020
How strongly does Tourette syndrome run in families?
A Swedish nationwide cohort study used health registries to identify 4,826 people with Tourette syndrome or chronic tic disorders and compared diagnoses in their biological relatives with those among matched population controls. First-degree relatives—parents, full siblings, and children—had 18.69 times the odds of a recorded Tourette syndrome or chronic tic disorder diagnosis (95% confidence interval 14.53–24.05). Second-degree relatives had an odds ratio of 4.58 (95% CI 3.22–6.52); third-degree relatives had an odds ratio of 3.07 (95% CI 2.08–4.51). Mataix-Cols et al., 2015
The increasing risk with closer genetic relatedness is one reason researchers conclude that inherited factors make a substantial contribution. Full siblings had considerably higher relative odds than maternal half siblings, despite sharing some social circumstances. The study estimated heritability of Tourette syndrome and chronic tic disorders together at 0.77, with a 95% confidence interval from 0.70 to 0.85. These are powerful population findings, yet their exact numerical interpretation depends on how diagnoses were captured in Swedish health records. Mataix-Cols et al., 2015
An odds ratio is a relative comparison, not a probability. An odds ratio of 18.69 does not mean a relative has an 18.69% chance of having Tourette syndrome, and it does not directly answer a parent's question about their future child's absolute risk. To estimate a percentage probability, researchers need baseline prevalence and an appropriate method for translating family aggregation into a recurrence estimate.
What is the risk for a child, sibling, or other relative?
Heiman and colleagues developed empirical recurrence-risk estimates for chronic tic disorders using available family-risk and population-prevalence data. Their estimate for first-degree relatives was 29.9% (95% CI 23.2%–38.5%). For second-degree relatives the study estimated 7.4% (95% CI 5.1%–10.4%). The outcome was chronic tic disorders as a category, including Tourette syndrome and other persistent tic disorders. These are model-derived group estimates, rather than results of a test of a particular parent or child. Heiman et al., 2020
The paper estimated chronic tic disorder recurrence of 33.7% among male relatives and 24.3% among female relatives in its analytical framework. These estimates are sensitive to how study populations and diagnosed cases are defined, and the confidence intervals are wide. Differences in diagnosis and help-seeking can also influence observed comparisons between boys and girls. A family's actual circumstances may differ from the populations on which the estimates were based. Heiman et al., 2020
A child of an affected parent, a full sibling of an affected child, a half sibling, and a distant cousin can each have a different family-history context. Multiple affected family members may prompt a more detailed review. The central distinction remains the one between the risk of any chronic tic disorder and the risk of Tourette syndrome specifically. Treating the two outcomes as synonyms overstates the precision of current counseling.
Why risk percentages and heritability percentages are different
Heritability describes the proportion of variation in a trait or underlying susceptibility in a studied population that is statistically attributed to genetic differences under a model. It does not tell us what percentage of one person's Tourette syndrome was 'caused by genes.' Nor does 77% heritability mean that 77 out of 100 children of an affected parent will have Tourette syndrome. Heritability varies with the sample, definition of the outcome, measurement accuracy, population, and statistical assumptions.
The Swedish family-register estimate of approximately 77% concerned clinically diagnosed Tourette syndrome and other chronic tic disorders. In a large Netherlands twin-family analysis using broader lifetime tic phenotypes, the estimated heritability was approximately 25%–37%, depending on how tic symptoms were defined. The studies answer different questions, and broader symptom reporting can produce different estimates from clinically recorded disorders. A 2025 genetics review summarized Tourette heritability findings more generally as roughly 50%–80%. Mataix-Cols et al., 2015 · Zilhão et al., 2017 · Fernandez, 2025
For a family discussing pregnancy or a child's development, a recurrence-risk estimate is usually a more practical starting point than heritability. Even then, the estimate is a range from a population model and cannot be turned into an individualized forecast without further information. The uncertainty interval expresses statistical uncertainty, not a guarantee about the range for any single family.
What do twin studies reveal?
Twins provide a natural way to examine genetic influence because identical twins share nearly all inherited DNA, whereas fraternal twins share about half of common segregating genetic variation on average. Researchers compare how often both twins show tic disorders or related symptoms. Higher similarity within identical pairs supports a genetic contribution, while cases in which identical twins differ show that shared DNA does not perfectly determine outcomes.
Early clinical twin research found more frequent agreement for Tourette syndrome and related tics among identical twins than among fraternal twins, but some cohorts were small. Larger twin-family studies broadened the observed phenotype to lifetime tic symptoms and also found meaningful genetic influence, with estimates changing according to the criteria used. A twin with tics therefore does not give a precise prediction about the other twin's diagnosis, tic severity, or long-term functioning. Zilhão et al., 2017
Is there a single gene for Tourette syndrome?
Research has not identified one universal Tourette syndrome gene. Genome-wide association studies examine common differences in DNA across thousands of participants and estimate which variants occur more often in affected than unaffected people. The genetic contribution appears highly polygenic: many common variants have small individual effects, and their combined influence may contribute to clinical susceptibility. Fernandez, 2025
Common variants and polygenic risk
A major 2019 genome-wide association study included 4,819 Tourette syndrome cases and 9,488 controls. The researchers studied widespread common-variant influences and polygenic scores. One prominent signal near FLT3 did not replicate in an independent population sample, a reminder that an interesting research association is not automatically a confirmed clinical gene test. The study advanced knowledge of genetic architecture without establishing an individual diagnostic DNA marker. Yu et al., 2019
A polygenic risk score combines statistical estimates for numerous variants. In research settings, higher scores can sometimes distinguish average susceptibility across large groups. Their predictive power for a single person is limited by incomplete variant discovery, ancestry differences, phenotype definitions, and the mismatch between statistical association and clinical decision thresholds. Current polygenic scores are not validated tools for telling a family whether one particular child will develop Tourette syndrome or how severe tics will become.
Rare variants and de novo changes
Rare coding variants and copy-number changes may make larger contributions in some individuals. A de novo variant is a genetic change that appears in the affected child and is not detectable as inherited from either parent by the study's methods. Exome-sequencing research has identified an excess of particular damaging de novo variants in some Tourette cohorts, implicating candidate genes and developmental pathways. This type of result supports genetic heterogeneity; it does not imply that all affected people share a single mutation. Willsey et al., 2017
The interpretation of rare variants requires careful evaluation of whether a specific finding actually disrupts the gene, whether the gene–condition association is robust, whether the variant is inherited or new, and whether the person's full clinical presentation matches an established genetic disorder. A variant appearing on a commercial sequencing report may be benign or of uncertain significance. Its presence alone cannot establish typical Tourette syndrome.
Why can Tourette syndrome occur without any family history?
An absence of known affected relatives is common enough to fit the genetic model. Parents without a diagnosis can transmit multiple susceptibility variants; a relative's mild childhood tics may have resolved or never been recognized; and a rare de novo genetic variant can occasionally contribute to risk. A small family, limited information about biological relatives, and differences in diagnosis can make inherited patterns difficult to see. A clinician does not require a positive family history to diagnose Tourette syndrome. CDC diagnosis · Willsey et al., 2017
A family may notice a pattern that seems to skip a generation, or relatives may display different kinds of tics. These observations are compatible with complex susceptibility and variable clinical expression. Such patterns should not be interpreted as evidence that a particular gene was silently carried in a Mendelian fashion without a clinical genetics assessment.
Does genetic risk overlap with ADHD, OCD, or autism?
Tourette syndrome frequently co-occurs with ADHD, OCD, and other developmental or mental health conditions. Genome-wide cross-disorder work suggests overlapping genetic liability across some of these categories, with particularly notable evidence for Tourette syndrome and OCD in certain analyses. Shared genetic influences do not make these diagnoses identical, and they do not mean that a relative's OCD or ADHD diagnosis proves that any particular Tourette-associated variant was transmitted. Tsetsos et al., 2021
Co-occurring conditions should be assessed according to their respective clinical criteria. Tourette syndrome requires a defined tic pattern, OCD involves obsessions or compulsions meeting its own criteria, and ADHD has separate developmental and functional requirements. An individual may have one, several, or none of these conditions. For the OCD-centered discussion, see OCD and Tic Disorders: Understanding the Connection, which owns that specific comparison within English Hub.
What role do environment, pregnancy, and stress play?
Researchers investigate prenatal, perinatal, infectious, immune, and other environmental associations with tic disorders. The CDC lists factors such as pregnancy complications, low birthweight, smoking during pregnancy, and infection among studied possibilities, while emphasizing that additional research is needed. An observed association does not demonstrate that a particular exposure caused Tourette syndrome in an individual child; studies must address confounding, measurement, and the possibility of shared familial influences. CDC
Stress, excitement, fatigue, and attention can affect when tics become more or less noticeable in some individuals. Such changes in expression must be distinguished from the original development of a neurodevelopmental tic disorder. If tics increase during an exam or a difficult period, that fluctuation does not establish that the situation caused Tourette syndrome, and it gives no basis for blaming a parent, teacher, or child.
Gene–environment interactions and epigenetic processes are active research topics. Their general biological plausibility exceeds the certainty with which any particular pathway can currently predict Tourette syndrome in a given family. The most appropriate evidence language for many proposed mechanisms remains preliminary rather than established clinical causality. Fernandez, 2025
Does Tourette syndrome affect sons and daughters differently?
Tourette syndrome is identified more often in boys than in girls in many datasets, prompting research into biological influences, detection, presentation, and healthcare access. The Swedish register study did not find a substantial difference in familial risk or estimated heritability between male and female affected probands. A later empirical recurrence model estimated a higher risk for male than female relatives. These analyses examine different questions and need not be treated as contradictory. Mataix-Cols et al., 2015 · Heiman et al., 2020
Sex-stratified population percentages are not a deterministic rule for a particular boy or girl. Likewise, the diagnosis of a tic disorder in a mother rather than a father does not supply a scientifically established inheritance equation that identifies which child will be affected.
Can a DNA test diagnose or predict Tourette syndrome?
There is currently no routinely validated single-gene panel, blood test, polygenic score, or prenatal screening test that can reliably diagnose or predict typical Tourette syndrome. Diagnosis rests on a professional evaluation of the types of tics, age at onset, duration, developmental history, and possible alternative causes. The CDC explicitly states that there is no single test such as a blood test that diagnoses Tourette syndrome. CDC diagnosis
Genetic testing may still be considered in selected situations when there are other significant developmental, neurological, congenital, or medical findings that suggest a separate genetic syndrome or require a broader medical evaluation. The decision then depends on the entire clinical presentation and the suspected diagnosis. A genetic counselor or medical geneticist can explain the indication, what the assay can detect, uncertain variants, incidental findings, and potential implications for relatives. CDC genetic testing
If a commercial service markets a 'Tourette risk gene' score, families should ask whether the test has demonstrated clinical validity and useful prediction in representative populations, and whether a result would actually change care. An elevated genetic association score is not a Tourette syndrome diagnosis, and an unremarkable result cannot rule it out.
Can genes predict tic severity or lifelong outcome?
Genetic factors may contribute to differences in symptom burden, and research has investigated whether higher aggregated genetic risk correlates with tic severity. However, the predictive accuracy of these observations is insufficient for a routine individualized forecast of tic intensity, pain, social interference, need for medication, or adult functioning. Even within one family, people with related genetic backgrounds may have very different experiences. Yu et al., 2019
Tics often wax and wane, and many people experience a decrease in severity during adolescence or adulthood, although some continue to have impairing symptoms. Clinical outcome also depends on co-occurring ADHD, OCD, anxiety or other concerns, social experiences, and access to appropriate support. None of those outcomes can be read directly from a family tree or current commercial Tourette genetic profile.
Does a genetic basis change treatment?
Genetic susceptibility does not imply that symptoms cannot respond to treatment. If tics do not cause distress or impairment, education, support, and watchful waiting may be appropriate. For bothersome tics, comprehensive behavioral intervention for tics (CBIT) is an evidence-based option; medication can be considered for suitable patients after assessment of possible benefits and adverse effects. Neither treatment selection nor response is currently determined by a routine Tourette DNA result. American Academy of Neurology guideline · CDC treatment
CBIT includes awareness training, competing response strategies, and interventions addressing situations that increase the burden of tics. It is a structured treatment of symptoms and functioning, not a procedure that changes the inherited DNA. Medication decisions require individualized review and monitoring. Research showing benefit in one tic-disorder patient group should not automatically be generalized to all ages, co-occurring conditions, or unusual tic-like presentations.
When is genetic counseling appropriate?
A genetic counseling consultation can be useful when someone with Tourette syndrome or a persistent tic disorder is planning a family, when multiple relatives are affected, when relatives want help understanding empirical recurrence estimates, or when additional developmental or medical findings raise questions about a different genetic diagnosis. The authors of the 2020 recurrence-risk study recommended counseling that addresses both the numerical estimates and their limitations. Heiman et al., 2020
Before a consultation, collect known diagnoses and symptom histories for parents, full and half siblings, children, grandparents, and other relatives. Separate confirmed Tourette syndrome from persistent motor/vocal tic disorders, brief childhood tics, and observations such as isolated blinking or throat clearing. Include the ages when symptoms appeared, whether they persisted, and whether other neurodevelopmental conditions were evaluated. This supports a clearer family history without assigning diagnoses to relatives.
A counselor can explain why a Swedish odds ratio, a 2020 recurrence percentage, and a heritability estimate have different meanings. The purpose is to make uncertainty comprehensible and support informed decisions, rather than offer a guarantee that a child will or will not develop Tourette syndrome.
Practical guidance for parents and family members
A family history of Tourette syndrome is valuable information for a clinician, but watching a child constantly for every twitch can add distress without improving diagnosis. Recurrent sudden movements or sounds, especially those causing pain, interference, or social problems, warrant discussion with a pediatrician or an appropriate specialist. A clinician can consider tic phenomenology, duration, development, medication effects, stereotypies, compulsions, functional tic-like symptoms, and neurological alternatives. CDC diagnosis
Support should respond to current needs. Educators can avoid punishment for involuntary tics, reduce bullying, and discuss suitable accommodations. Families can distinguish the person's tic disorder from separately assessed ADHD, OCD, autism, or anxiety. A genetic explanation does not replace compassionate social support or individualized treatment. CDC information for educators
What the evidence establishes—and what remains uncertain
The high-confidence conclusion is that Tourette syndrome and related chronic tic disorders have a substantial inherited component. This is supported by converging family registers, twin studies, and molecular genetic data. The exact contribution of identified variants to any individual's symptoms, the nature of many causal pathways, and reliable individualized prediction remain developing areas. Some genomic cohorts are smaller than those for other common conditions, and historically disproportionate representation of European-ancestry participants limits generalization. Fernandez, 2025 · Yu et al., 2019
Research estimates also shift when studies combine Tourette syndrome with other chronic tic disorders, use clinical diagnoses rather than self-reported symptoms, examine children versus adults, or capture different levels of severity. Population-register samples can undercount undiagnosed tics. These differences should be preserved in scientific writing and genetic counseling rather than flattened into a single universal percentage.
Frequently asked questions
Is Tourette syndrome hereditary?
Yes. It runs in families and has a substantial genetic contribution, although its inheritance is typically complex rather than the transmission of one specific gene. Fernandez, 2025
If I have Tourette syndrome, will my child inherit it?
Your child has a higher-than-average risk of developing a chronic tic disorder, but a diagnosis is not inevitable. A commonly quoted approximately 30% figure concerns chronic tic disorders collectively, not Tourette syndrome alone or every particular family. Heiman et al., 2020
Can Tourette syndrome skip a generation?
Family histories sometimes appear that way because genetic susceptibility can be carried without recognized symptoms, tics may be mild or resolve, and multiple variants jointly influence expression. This observation does not prove a particular recessive or dominant gene.
Can Tourette syndrome occur without a family history?
Yes. Family histories can be incomplete, susceptibility variants can be inherited from unaffected relatives, and some risk variants may occur de novo. A positive family history is not necessary for the clinical diagnosis.
What percentage of Tourette syndrome is genetic?
Published heritability estimates often fall in a broad range around 50%–80% for Tourette syndrome and clinically defined tic disorders. Heritability is a population statistic and is not a person's probability of transmitting the condition. Fernandez, 2025
Are boys more likely than girls to develop Tourette syndrome?
Tourette syndrome is diagnosed more frequently in boys in many studies, but a child's sex alone does not provide a sufficiently precise prediction. Risk estimates must be interpreted alongside the study's diagnostic definitions and ascertainment.
Is there a prenatal or at-home genetic test for Tourette syndrome?
There is no clinically validated genetic test that reliably predicts typical Tourette syndrome in a fetus or child. Genetic evaluation may be useful for other reasons when additional findings point to a separately diagnosable condition. CDC diagnosis
Does genetic risk mean treatment will not work?
No. CBIT and other clinically selected approaches can help manage impairing tics without altering a person's DNA. Clinical decisions depend on present impairment and treatment preferences. AAN guideline
Related English Hub articles
Genetic overlap and clinical differentiation are discussed in OCD and Tic Disorders: Understanding the Connection and OCD vs. Tourette Syndrome: What Is the Difference?. Related OCD-specific inheritance questions belong to Is OCD Hereditary? Genetics, Family Risk, and Twin Studies.
Related Articles
References
American Academy of Neurology. (2019). Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. https://doi.org/10.1212/WNL.0000000000007466.
Centers for Disease Control and Prevention. (2024). About Tourette syndrome. https://www.cdc.gov/tourette-syndrome/about/index.html.
Centers for Disease Control and Prevention. (2026). Diagnosing tic disorders. https://www.cdc.gov/tourette-syndrome/diagnosis/index.html.
Centers for Disease Control and Prevention. Treatment of Tourette syndrome. https://www.cdc.gov/tourette-syndrome/treatment/index.html.
Fernandez, T. V. (2025). Genetics of Tourette syndrome. Psychiatric Clinics of North America, 48(1), 1–13. https://doi.org/10.1016/j.psc.2024.08.002.
Heiman, G. A., Rispoli, J., Seymour, S., Leckman, J. F., King, R. A., & Fernandez, T. V. (2020). Empiric recurrence risk estimates for chronic tic disorders: Implications for genetic counseling. Frontiers in Neurology, 11, 770. https://doi.org/10.3389/fneur.2020.00770.
Mataix-Cols, D., et al. (2015). Familial risks of Tourette syndrome and chronic tic disorders: A population-based cohort study. JAMA Psychiatry, 72(8), 787–793. https://doi.org/10.1001/jamapsychiatry.2015.0627.
Tsetsos, F., et al. (2021). Investigating the shared genetic basis across Tourette syndrome and related neurodevelopmental disorders. Biological Psychiatry. https://pubmed.ncbi.nlm.nih.gov/33714545/.
Willsey, A. J., et al. (2017). De novo coding variants are strongly associated with Tourette disorder. Neuron, 94(3), 486–499.e9. https://doi.org/10.1016/j.neuron.2017.04.024.
Yu, D., et al. (2019). Interrogating the genetic determinants of Tourette syndrome and other tic disorders through genome-wide association studies. American Journal of Psychiatry, 176(3), 217–227. https://doi.org/10.1176/appi.ajp.2018.18070857.
Zilhão, N. R., et al. (2017). Heritability of tic disorders: A twin-family study. Psychological Medicine, 47(6), 1085–1096. https://doi.org/10.1017/S0033291716002981.